Chord Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Geneva
Business model:B2B

Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 16M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Chord Therapeutics

Name Criteria
Denmark Acarix
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Achilles Therapeutics
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Adrenomed AG
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Algo Therapeutix
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden AMRA
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Anaconda Biomed
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top